| MR编号 | DE/H/1949/001 |
|---|
| 药品名称 | Vaxigrip Tetra |
|---|
| 活性成分 | - A/Cambodia/e0826360/2020 (H3N2)-like virus 15.0 µg
- A/Victoria/4897/2022 (H1N1)pdm09-like virus 15.0 µg
- B/Phuket/3073/2013 15.0 µg
- B/Washington/02/2019-like strain 15.0 µg
|
|---|
| 剂型 | SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE |
|---|
| 上市许可持有人 | Sanofi Pasteur or Sanofi Pasteur MSD;
Speciality for France Sanofi Pasteur SA is MAH and Sanofi Pasteur MSD SNC is legally responsible for placing the product on the market.
For Germany:
Sanofi Pastuer MSD GmbH Alexanderufer 3 10117 Berlin Germany |
|---|
| 参考成员国 - 产品名称 | Germany (DE) Vaxigrip Tetra |
|---|
| 互认成员国 - 产品名称 | - Estonia (EE)
- Denmark (DK)
- Belgium (BE)
Vaxigrip Tetra suspension injectable en seringue pré-remplie - Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
VaxigripTetra 15 míkróg Stungulyf, dreifa í áfylltri sprautu - United Kingdom (Northern Ireland) (XI)
quadrivalent influenza vaccine (split virion, inactivated) sanofi pasteur MSD - Ireland (IE)
quadrivalent influenza vaccine (split virion, inactivated) sanofi pasteur MSD - Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
VAXIGRIP TETRA® - Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
VaxigripTetra - Latvia (LV)
VaxigripTetra suspensija injekcijām pilnšļircē - Lithuania (LT)
VaxigripTetra injekcinė suspensija užpildytame švirkšte - Hungary (HU)
VAXIGRIP TETRA szuszpenziós injekció előretöltött fecskendőben - Bulgaria (BG)
- Cyprus (CY)
- Czechia (CZ)
VaxigripTetra - Romania (RO)
- Slovakia (SK)
VaxigripTetra - Slovenia (SI)
- Malta (MT)
Vaxigrip Tetra - Croatia (HR)
|
|---|
| 许可日期 | 2016/06/21 |
|---|
| 最近更新日期 | 2025/02/07 |
|---|
| 药物ATC编码 | - J07BB02 influenza, inactivated, split virus or surface antigen
|
|---|
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4：Biological: Vaccine
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|